Animal-origin-free culture medium of bordetella pertussis and fermentation culture method

Through the culture medium of non-animal origin pertussis and optimized fermenter culture method, the problems of low antigen expression and low production efficiency are solved, efficient bacterial seed preparation and high antigen expression are achieved, production costs are reduced, and the scale of pertussis vaccine is reduced. Chemical production laid the foundation.

CN118909867APending Publication Date: 2024-11-08CHENGDU INST OF BIOLOGICAL PROD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411138818.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

In the production of pertussis vaccine, the co-purification process leads to unstable antigen ratio, affecting product quality; the component purification process is complex and high cost, resulting in low production efficiency and difficult to achieve high antigen expression.

Method used

Provide an animal-free Bacillus pertussis culture medium. By combining component A and component B, combining yeast peptone and other components, the culture conditions are optimized, and the bacterial growth rate and antigen expression level are improved. The fermenter culture method is adopted. Control DO and pH values ​​to achieve efficient bacterial seed preparation.

Benefits of technology

It significantly improves the efficiency of strain preparation and antigen expression level, shortens the preparation cycle, improves batch consistency, reduces production costs, lays the foundation for the component purification process, and supports the large-scale production of pertussis vaccine.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118909867A_ABST
    Figure CN118909867A_ABST
Patent Text Reader

Abstract

The invention discloses an animal origin-free culture medium of bordetella pertussis. The animal origin-free culture medium is mainly prepared from a component A and a component B in a mass ratio of (19.65-48.6): (0.077-0.281). An animal-origin-free culture medium of the bordetella pertussis is combined with a specific strain preparation process and a fermentation culture process, so that the growth rate and the highest bacterium concentration of the bordetella pertussis in the culture process are relatively high, and the antigen expression quantity is also high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention specifically relates to an animal-free culture medium and a fermentation culture method for Bordetella pertussis. Background Art

[0002] Whooping cough is caused by infection with Bordetella pertussis (Bp), which can occur in all age groups. Humans are the only host of the bacteria and are highly contagious. Since my country implemented the pertussis vaccine immunization program in 1978, the annual incidence of pertussis has dropped from 100 / 100,000 to 200 / 100,000 in the 1960s and 1970s to less than 0.5 / 100,000 in 2018. In recent years, the incidence of pertussis has gradually increased, and the distribution of cases has shifted to adolescents and adults, resulting in the "re-emergence of pertussis."

[0003] At present, domestic pertussis vaccine manufacturers generally adopt the co-purification process, that is, extract and purify two antigen components, pertussis toxin (PT) and filamentous hemagglutinin (FHA), simultaneously during the extraction process. The advantage of this process is that the required antigens can be obtained at one time, and the purity and yield can be improved by technical means such as gradient centrifugation. However, there are also some problems with the co-purification process, such as the unstable antigen ratio between batches, which leads to the problem of consistency of product quality. Developed countries such as Europe and the United States have adopted the latest generation of group-by-group purification process, that is, antigens PT and FHA are prepared separately by column chromatography, which enables various pertussis antigen components to be quantitatively added during vaccine preparation, and the antigen component ratio in the vaccine is constant. Therefore, the pertussis vaccine prepared by this process has the characteristics of less side effects, higher safety, and better batch consistency. This is also the new generation of pertussis vaccine preparation process currently being developed by domestic vaccine companies, and the development of this process can also lay the foundation for the development of pertussis vaccines for adolescents and adults. However, due to the complexity of the group-by-group purification process and the low antigen yield, the production cost of the pertussis vaccine produced by this process is relatively high. In order to improve the efficiency of large-scale production of component pertussis vaccines and reduce their production costs, it is first necessary to improve the production efficiency of the Bordetella pertussis culture stage and increase the expression levels of antigens PT and FHA in the fermenter culture stage.

[0004] Bordetella pertussis is an obligate aerobe with a small size (0.2-0.5um×0.5-1.5um). It has glycolysis dysfunction during its growth and can usually only use amino acids as carbon, nitrogen and energy sources. The bacterial growth requires high nutrition and is easily affected by the environment to cause phase variation and gene regulation, resulting in low or no PT expression. Currently, pertussis vaccine manufacturers generally inoculate Bordetella pertussis into Bojangles medium containing sheep blood or activated carbon semi-integrated medium (containing bovine acid hydrolyzed casein) to recover and amplify the strain. After amplification, the strain is inoculated into liquid SS medium and its improved medium to express the antigens PT and FHA. When this process is used for cultivation, the bacterial growth efficiency is low and the bacterial concentration in the tank is not high (OD 550 Generally, the antigen level is between 5.0 and 6.0, and the antigen level expressed is low (PT: 1 to 5 ug / ml fermentation liquid). In addition, the antigen FHA is a filamentous structure (2 nm wide and 45-50 nm long), which is easily damaged by physical shear force during the culture process. For example, the physical shear force generated by the bubble burst and stirring blades during the culture process can lead to its degradation. Therefore, it is very difficult to achieve high expression in the culture of Bordetella pertussis and the preparation of antigens in the fermenter. Summary of the invention

[0005] The present invention aims to provide an animal-free culture medium for Bordetella pertussis and a fermenter culture method using the culture medium to support efficient antigen expression, so as to improve the high bacterial concentration of Bordetella pertussis and high antigen expression in the fermenter preparation stage.

[0006] The present invention provides an animal-derived-free culture medium for Bordetella pertussis, which mainly consists of component A and component B;

[0007] The component A is composed of the following raw materials in parts by weight:

[0008] Component A: 10.0-20.0 parts of sodium glutamate, 0.1-0.6 parts of proline, 2-7 parts of NaCl, 0.4-1.2 parts of KH2PO4, 0.1-0.5 parts of KCl, 0.05-0.3 parts of MgCl2·6H2O, 6.0-10.0 parts of Tris, 1.0-2.0 parts of 2,6-di-O-methyl-β-cyclodextrin, and 0-7.0 parts of yeast peptone;

[0009] The component B is composed of the following raw materials in parts by weight:

[0010] 0.01-0.05 parts of cysteine ​​hydrochloride, 0.05-0.15 parts of reduced glutathione, 0.005-0.025 parts of FeSO4.7H2O, 0.01-0.05 parts of ascorbic acid, and 0.002-0.006 parts of niacin;

[0011] The mass ratio of component A to component B is 19.65-48.6:0.077-0.281.

[0012] Furthermore, the component A is composed of the following raw materials in parts by weight:

[0013] 12.0 parts of sodium glutamate, 0.3 parts of proline, 2.5 parts of NaCl, 0.6 parts of KH2PO4, 0.2 g of KCl, 0.25 parts of MgCl2·6H2O, 6.1 parts of Tris, 1.0 parts of 2,6-di-O-methyl-β-cyclodextrin, and 5.0 parts of yeast peptone;

[0014] The component B is composed of the following raw materials in parts by weight:

[0015] 0.04 parts of cysteine ​​hydrochloride, 0.1 parts of reduced glutathione, 0.015 parts of FeSO4.7H2O, 0.02 parts of ascorbic acid, 0.004 parts of niacin;

[0016] The mass ratio of component A to component B is 27.95:0.179.

[0017] Furthermore, it also includes component C; the component C is 10.0-20.0 parts of agar powder, preferably 15.0 parts of agar powder; the mass ratio of the component C to the component A and the component B is 10.0-20.0:19.65-48.6:0.077-0.281, preferably 15.0:27.95:0.179.

[0018] Furthermore, the proline is L-proline; the cysteine ​​hydrochloride is L-cysteine ​​hydrochloride; and the ascorbic acid is L-ascorbic acid.

[0019] The present invention also provides a use of the above culture medium in fermentation and culture of Bordetella pertussis.

[0020] The present invention also provides a fermentation and culture method of Bordetella pertussis, which comprises the following steps:

[0021] 1) Take the Bordetella pertussis strain and inoculate it on the solid culture medium for 48-72 hours, wash off the bacterial lawn with water, and inoculate it into the liquid culture medium. The initial OD 550 Controlled at 0.1-0.2, cultured until OD 550 When the OD reaches 4-6, take the bacterial solution and inoculate it into liquid culture medium. 550 Controlled at 0.1-0.2, cultured with aeration and stirring until OD 550 When the value reaches 4-6, the bacteria for fermentation are obtained;

[0022] 2) Take the fermentation strain obtained in step 1) and inoculate it into a fermentation tank containing liquid culture medium. The initial OD 550Control the pH value at 0.1-0.2, ventilate and stir the liquid surface, control the DO value at 30%-50%, and the pH value at 7.2-7.6, until the bacteria stop growing;

[0023] The solid culture medium is prepared by dissolving and sterilizing the aforementioned culture medium with water;

[0024] The liquid culture medium is prepared by dissolving the aforementioned culture medium in water and sterilizing it.

[0025] Furthermore, the preparation method of the solid culture medium is:

[0026] Take component A and component C, mix them, add 38-40℃ water for injection to dissolve, adjust the pH to 7.1-7.3, sterilize by high pressure, and cool to 40-50℃ to obtain liquid A; take component B, add 38-40℃ water for injection to dissolve, filter to obtain liquid B; mix liquid A and liquid B, and solidify to obtain;

[0027] The preparation method of the liquid culture medium is:

[0028] Mix component A and component B, dissolve in 38-40°C water for injection, adjust the pH to 7.1-7.3, and filter to obtain the product.

[0029] Furthermore, the culture temperature in step 1) is 35-37°C.

[0030] Furthermore, in step 2), the pH value is adjusted with acid.

[0031] Furthermore, the acid is a hydrochloric acid solution or a lactic acid solution.

[0032] The invention is based on the Stainer-Scholte liquid medium (SS medium), by adding a specific non-animal-derived peptone, namely yeast peptone, and adjusting the dosage ratio of other components accordingly, so that the growth rate and the highest bacterial concentration of Bordetella pertussis in the culture process are higher, and the antigen expression amount is also higher. The supernatant obtained by fermentation is used as the raw material for vaccine preparation, which has high safety because it does not contain animal-derived components, and at the same time, the high antigen expression amount lays a foundation for the purification process of Bordetella pertussis.

[0033] The culture medium of the present invention is used for the preparation of strains for fermentation of Bordetella pertussis. Under the mode of one-generation solid culture and multi-generation liquid culture amplification, the preparation efficiency of strains is greatly improved, and the preparation cycle is shortened from the traditional 7 to 9 days to 5 to 6 days. At the same time, since it is easier to detect and control the concentration of bacteria in the liquid culture stage of strains, the process control ability of the strain preparation process is greatly improved, and the batch consistency of the fermentation strains is better; in the fermenter culture stage, by optimizing the ventilation mode, dissolved oxygen level control and pH control method of the culture process, the ability of the culture medium of the present invention to support bacterial growth and antigen expression is fully exerted, laying the foundation for the development of strain preparation technology and fermentation technology of component pertussis vaccine in the future, greatly improving the strain preparation efficiency and antigen expression level. The component pertussis vaccine will have the ability of large-scale mass production in the future, which will also be beneficial to enterprises to reduce costs and increase efficiency, and have practical promotion and application value.

[0034] Obviously, according to the above contents of the present invention, in accordance with common technical knowledge and customary means in the art, without departing from the above basic technical ideas of the present invention, other various forms of modification, replacement or change may be made.

[0035] The above contents of the present invention are further described in detail below through specific implementation methods in the form of embodiments. However, this should not be understood as the scope of the above subject matter of the present invention being limited to the following examples. All technologies realized based on the above contents of the present invention belong to the scope of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 Effects of adding different types of peptones to SS medium on the expression of antigen PT;

[0037] Figure 2 Growth of Bordetella pertussis at different dilutions on PP1SM plate culture medium with different salt concentrations (a. Bordetella pertussis liquid 10 3× Dilute and inoculate PP1SM solid medium; b. Bordetella pertussis liquid 10 3× Dilute and inoculate low-salt PP1SM solid medium; c. Bordetella pertussis liquid 10 7× Dilute and inoculate PP1SM solid medium; d. Bordetella pertussis liquid 10 7× Dilute and inoculate low-salt PP1SM solid medium);

[0038] Figure 3 Bacterial growth curve. DETAILED DESCRIPTION

[0039] Example 1 Preparation of liquid culture medium of Bordetella pertussis of the present invention

[0040] 1L culture medium formula:

[0041] Component A: sodium glutamate 12.0 g, L-proline 0.3 g, NaCl 2.5 g, KH2PO4 0.6 g, KCl 0.2 g, MgCl2·6H2O 0.25 g, Tris 6.1 g, 2,6-di-O-methyl-β-cyclodextrin 1.0 g, yeast peptone 5.0 g;

[0042] Component B: L-cysteine ​​hydrochloride 0.04g, reduced glutathione 0.1g, FeSO4.7H2O 0.015g, L-ascorbic acid 0.02g, niacin 0.004g;

[0043] Preparation method: Mix component A and component B, add 800 ml of 38-40°C water for injection, dissolve and mix well, adjust the pH to 7.1-7.3 with hydrochloric acid solution, then make up to 1L with 38-40°C water for injection, and finally filter and sterilize.

[0044] Example 2 Preparation of solid culture medium of Bordetella pertussis of the present invention

[0045] 1L solid culture medium formula:

[0046] Component A: sodium glutamate 12.0 g, L-proline 0.3 g, NaCl 2.5 g, KH2PO4 0.6 g, KCl 0.2 g, MgCl2·6H2O 0.25 g, Tris 6.1 g, 2,6-di-O-methyl-β-cyclodextrin 1.0 g, yeast peptone 5.0 g;

[0047] Component B: L-cysteine ​​hydrochloride 0.04g, reduced glutathione 0.1g, FeSO4.7H2O 0.015g, L-ascorbic acid 0.02g, niacin 0.004g;

[0048] Component C: agar powder 15.0g.

[0049] Preparation method:

[0050] 1) Mix component A and component C, add 700 ml of 38-40°C water for injection, adjust the pH to 7.1-7.3 with hydrochloric acid solution, and then make up to 900 ml with 38-40°C water for injection. Finally, sterilize at 121°C for 30 minutes to obtain solution A.

[0051] 2) Take component B, add 100 ml of 38-40°C water for injection, dissolve and mix evenly, and filter to obtain liquid B;

[0052] 3) Take the solution A obtained in step 1) and cool it to 40-50°C, add the solution B obtained in step 2) and mix well, dispense into a plate, and solidify to obtain the product.

[0053] Example 3 Fermentation culture of Bordetella pertussis of the present invention

[0054] 1) The freeze-dried strains of Bordetella pertussis were inoculated on the solid culture medium obtained in Example 2, cultured at 35-37°C for 48-72h, washed with sterile water, and inoculated into the liquid culture medium obtained in Example 1. The initial OD 550 Control the temperature between 0.1 and 0.2, and culture at 35 to 37°C until the OD 550 When the OD reaches 4-6, the bacterial solution is taken and inoculated into the liquid culture medium obtained in Example 1. The initial OD 550 Control the temperature at 0.1-0.2, and culture at 35-37℃ with aeration and stirring until the OD 550 When it reaches 4 to 6, you can get the bacteria for fermentation.

[0055] 2) The bacterial liquid obtained in step 1) is inoculated into a fermenter, wherein the culture medium in the fermenter is the liquid culture medium obtained in Example 1, the initial OD550 is controlled at 0.1-0.2, aeration is carried out above the liquid surface, and the culture is stirred. During the culture process, the dissolved oxygen (DO) in the fermentation liquid is controlled at 30%-50%, and the pH is controlled at 7.2-7.6 with a hydrochloric acid solution. The fermentation culture is terminated when bacterial growth stops.

[0056] Example 4 Fermentation culture of Bordetella pertussis of the present invention

[0057] 1) Take the freeze-dried strain of Bordetella pertussis and inoculate it on the solid culture medium obtained in Example 2, culture it at 35-37°C for 48-72h, wash the bacterial lawn with water, and inoculate it in the liquid culture medium obtained in Example 1. The initial OD 550 Control the temperature between 0.1 and 0.2, and culture at 35 to 37°C until the OD 550 When the OD reaches 4-6, take the bacterial solution and inoculate it into the liquid culture medium obtained in Example 1. 550 Control the temperature at 0.1-0.2, and culture at 35-37℃ with aeration and stirring until the OD 550 When it reaches 4 to 6, you can get the bacteria for fermentation.

[0058] 2) The bacterial solution obtained in step 1) was inoculated into a fermenter, and the medium formula in the fermenter was the liquid medium obtained in Example 1, and the initial OD 550 The pH value is controlled at 0.1-0.2, aeration is performed above the liquid surface, and the culture is stirred. During the culture process, the DO is controlled at 30%-50%, and the pH is controlled at 7.2-7.6 with lactic acid solution. The fermentation culture is terminated when the bacterial growth stops.

[0059] The beneficial effects of the present invention are described below through test examples.

[0060] Experimental Example 1 Development of Animal-free Culture Medium and Culture Process for Component Acellular Pertussis Vaccine 1. Research on Animal-free Culture Medium

[0061] 1. No animal-derived peptone screening in the culture medium

[0062] On the basis of previous experiments, more than ten different sources of animal-free peptones were screened by shake flask culture experiments using SS medium (the formula per liter of culture medium is: sodium glutamate 10.7g, L-proline 0.24g, NaCl 2.5g, KH2PO4 0.5g, KCl 0.2g, MgCl2·6H2O 0.1g, CaCl2 0.02g, Tris 6.1g, 2,6-di-O-methyl-β-cyclodextrin 1.0g, L-cysteine ​​hydrochloride 0.04g, reduced glutathione 0.1g, FeSO4.7H2O0.01g, L-ascorbic acid 0.02g, niacin 0.004g) as the basic culture medium. The results are shown in Figure 2. Figure 1 .

[0063] from Figure 1 It can be seen that when Bordetella pertussis was fermented and cultured in SS medium containing yeast peptone, the PT expression level in the culture supernatant was as high as 12 μg / ml of bacterial liquid, which was significantly higher than that in SS medium containing other animal-free peptones. Therefore, yeast peptone was determined to be used in the development of culture medium formula for Bordetella pertussis culture.

[0064] 2. Development of culture medium formula for Bordetella pertussis culture

[0065] Based on the SS medium supplemented with yeast peptone, DOE (uniform experimental design) was used to design 6 experimental levels for the 8 medium components in the medium, and 12 groups of experiments were arranged. The medium formula for the culture of Bordetella pertussis was screened through shake flask experiments. The details are shown in Table 1.

[0066]

[0067] 0.04g L-cysteine ​​hydrochloride, 0.1g reduced glutathione, 0.015g FeSO4.7H2O, 0.02g L-ascorbic acid, 0.004g nicotinic acid, 5.0g yeast peptone, dissolve and mix with 800ml 38-40℃ water for injection, adjust pH to 7.1-7.3 with hydrochloric acid solution, then dilute to 1000ml with 38-40℃ water for injection, and finally filter and sterilize. It is most beneficial for fermentation and culture of Bordetella pertussis, and can obtain OD 550 The bacterial concentration was >7, and the expression of antigens PT and FHA were both higher than 20 μg / ml fermentation broth. Therefore, it was used as the basis for further optimization of the culture medium for Bordetella pertussis culture, and the culture medium formula was named PP1SM medium.

[0068] 3. Investigation of salt concentration in culture medium

[0069] Solid culture medium was prepared by adding 1.5% agar powder to PP1SM culture medium, and the NaCl concentration in the formula was adjusted (the concentrations were 7.0 g / L and 2.5 g / L, respectively), to investigate the effect of the NaCl concentration in PP1SM culture medium on the growth of Bordetella pertussis, namely, the color, morphology, glossiness of the colonies, and the number of single colonies formed. The preparation method of the solid culture medium is as follows:

[0070] 1) Take sodium glutamate, L-proline, NaCl, KH2PO4, KCl, MgCl2·6H2O, Tris, 2,6-di-O-methyl-β-cyclodextrin, yeast peptone and agar powder, add 38-40℃ water for injection and mix well, adjust the pH to 7.1-7.3 with hydrochloric acid solution, then make up to volume with 38-40℃ water for injection, and finally sterilize at 121℃ for 30min to obtain solution A;

[0071] 2) Take L-cysteine ​​hydrochloride, reduced glutathione, FeSO4.7H2O, L-ascorbic acid and nicotinic acid, add 38-40℃ water for injection, dissolve and mix, and filter to obtain solution B;

[0072] 3) Take the solution A obtained in step 1) and cool it to 40-50°C, add the solution B obtained in step 2) and mix well, dispense into a plate, and solidify to obtain the product.

[0073] Results Figure 2 ,from Figure 2 It can be seen that the colonies formed by the two groups of culture media are all small gray-white dew-shaped colonies with neat edges, glossy and translucent, which are consistent with the characteristics of pertussis colonies. When the NaCl concentration is 7.0g / L, the number of colonies formed is small, which is not conducive to the growth of Bordetella pertussis. When the NaCl concentration is reduced to 2.5g / L, the number of colonies formed increases significantly, which is more conducive to the growth of Bordetella pertussis.

[0074] 4. Effects of salt concentration and buffer concentration in culture medium on antigen expression

[0075] The NaCl and Tris concentrations in the PP1SM medium were investigated in quadruplicate tanks. The growth curves are shown in Figure 3 , the highest bacterial concentration (OD 550 ) and antigen expression levels are shown in Table 2.

[0076] Table 2 Effects of different NaCl concentrations and Tris concentrations on fermentation culture of Bordetella pertussis

[0077]

[0078] from Figure 3 It can be seen that the bacterial growth rate in the first and fourth parallel tanks is faster. From Table 2, it can be seen that the bacterial concentration (OD 550) and PT antigen expression were both high. Combined with "3. Investigation of salt concentration in culture medium", when the NaCl concentration was 2.5g / L, it was more conducive to the growth of bacteria on PP1SM plate culture medium. Therefore, the fourth group of culture medium formula was selected for fermentation tank culture and strain culture of Bordetella pertussis, and it was named mPP1SM liquid culture medium, that is, the culture medium formula and preparation method per liter were as follows: sodium glutamate 12.0g, L-proline 0.3g, NaCl 2.5g, KH2PO4 0.6g, KCl 0.2g, MgCl2·6H2O0.25g, Tris 6.1g, 2,6-di-O-methyl-β-cyclodextrin 1.0g, L-cysteine ​​hydrochloride 0.04g, reduced glutathione 0.1g, FeSO4.7H2O 0.015g, L-ascorbic acid 0.02g, niacin 0.004g, yeast peptone 5.0g, and 800ml was used. After dissolving and mixing with 38-40℃ water for injection, adjust the pH to 7.1-7.3 with hydrochloric acid solution, then make up to 1000ml with 38-40℃ water for injection, and finally filter and sterilize to obtain mPP1SM liquid culture medium.

[0079] 2. Research on fermentation and cultivation technology of Bordetella pertussis

[0080] 1. Methods

[0081] 1.1 Preparation process of fermentation strains

[0082] First generation bacterial culture (bacterial recovery): freeze-dried bacteria of phase I Bordetella pertussis CS strain (CMCC 58003) were inoculated on mPP1SM solid medium (1.5% agar powder was added to the aforementioned mPP1SM liquid medium), and cultured in a 35-37°C incubator for 48-72 hours for subculture;

[0083] Second generation bacterial culture: Wash off the first generation bacterial moss and inoculate into mPP1SM liquid medium. The initial OD 550 Controlled at 0.1-0.2, cultured at 35-37℃ constant temperature with shaking for 15-20h, OD 550 When the number reaches 4 to 6, it is used for passage;

[0084] Third-generation bacterial culture: The second-generation bacterial strain was inoculated into mPP1SM liquid medium, and the initial OD 550 Controlled at 0.1-0.2, cultured at 35-37℃ with aeration and stirring for 15-24h, OD 550 When the number reaches 4 to 6, it is used to inoculate the fermentation tank.

[0085] 1.2. Fermentation tank culture process research

[0086] Fermentation tank culture 1: The third generation strain was inoculated into the fermentation tank, and the culture medium in the fermentation tank was mPP1SM liquid culture medium, with an initial OD550 The DO is controlled at 0.1-0.2, and the surface layer above the liquid is ventilated and stirred. The culture process simulates the culture process of shake flasks and traditional fermentation tanks. The DO is not controlled, and the stirring speed and ventilation volume are not changed throughout the whole process. The pH is controlled at 7.2-7.6 with hydrochloric acid solution, and the fermentation culture is terminated when the bacterial growth stops.

[0087] Fermentation tank culture 2: The third generation strain was inoculated into the fermentation tank, and the medium in the fermentation tank was mPP1SM liquid medium, with an initial OD 550 The DO is controlled at 0.1-0.2, and the tank bottom is deeply ventilated and stirred for cultivation. During the cultivation process, the DO is controlled at 80%-100%, and the pH is controlled at 7.2-7.6 with hydrochloric acid solution. The fermentation culture is terminated when the bacterial growth stops.

[0088] Fermentation tank culture 3: The third generation strain was inoculated into the fermentation tank, and the medium in the fermentation tank was mPP1SM liquid medium, with an initial OD 550 The pH value is controlled at 0.1-0.2, and the surface layer above the liquid is ventilated and stirred for cultivation. During the cultivation process, the DO is controlled at 80%-100%, and the pH value is controlled at 7.2-7.6 with hydrochloric acid solution. The fermentation culture is terminated when the bacterial growth stops.

[0089] Fermentation tank culture 4: The third generation strain was inoculated into the fermentation tank, and the culture medium in the fermentation tank was mPP1SM liquid culture medium, with an initial OD 550 The pH value is controlled at 0.1-0.2, and the surface layer above the liquid is ventilated and stirred for cultivation. During the cultivation process, the DO is controlled at 30%-50%, and the pH value is controlled at 7.2-7.6 with hydrochloric acid solution. The fermentation culture is terminated when the bacterial growth stops.

[0090] Fermentation tank culture 5: The third generation strain was inoculated into the fermentation tank, and the culture medium in the fermentation tank was mPP1SM liquid culture medium, with an initial OD 550 The pH value is controlled at 0.1-0.2, the surface layer above the liquid is ventilated and stirred for cultivation, the DO is controlled at 30%-50% during the cultivation process, the pH value is not adjusted throughout the whole process, and the fermentation cultivation is terminated when the bacterial growth stops.

[0091] Fermentation tank culture 6: The third generation strain was inoculated into the fermentation tank, and the culture medium in the fermentation tank was mPP1SM liquid culture medium, and the initial OD 550 The pH value is controlled at 0.1-0.2, the surface layer above the liquid is ventilated and stirred, the DO is controlled at 30%-50% during the culture process, the pH is controlled at 7.2-7.6 with lactic acid solution, and the fermentation culture is terminated when the bacterial growth stops.

[0092] Fermentation tank culture 7: The third generation strain was inoculated into the fermentation tank, and the culture medium in the fermentation tank was mPP1SM liquid culture medium, and the initial OD 550The pH value is controlled at 0.1-0.2, the surface layer above the liquid is ventilated and stirred, the DO is controlled at 30%-50% during the culture process, and the pH is controlled at 7.2-7.6 with a phosphoric acid solution. The fermentation culture is terminated when the bacterial growth stops.

[0093] 1.3 Fermentation broth test

[0094] The bacterial concentration in the bacterial solution was detected by a spectrophotometer, measuring the optical density at a wavelength of 550nm, i.e. OD 550 When the optical density of the bacterial solution is greater than 0.8, the bacterial solution needs to be diluted to an optical density between 0.2 and 0.8 for detection. The product of the optical density value and the dilution multiple is the OD of the tested bacterial solution. 550 value.

[0095] The expression amounts of antigens PT and FHA in the culture supernatant are quantitatively detected by ELISA method, and the specific method is as follows: the coating solution is used to dilute the PT or FHA monoclonal antibody respectively and then added to the ELISA plate for coating the ELISA plate; the blocking solution is added to block the ELISA plate; the supernatant of the bacterial solution is diluted after centrifugation and then added to the ELISA plate; the PT or FHA monoclonal antibody labeled with horseradish peroxidase is added to the ELISA plate respectively; TMB color developing solution is added for color development; sulfuric acid solution is added to stop the color development; OD value is measured at a dual wavelength of 450nm / 630nm; finally, the PT and FHA contents in the bacterial solution are calculated by a standard curve drawn by a PT or FHA standard product, and a PT or FHA positive quality control is set at the same time to control the recovery rate within the range of 90-110%.

[0096] 2. Results

[0097] The specific results of the bacterial liquid test are shown in Table 3.

[0098] Table 3 Bacterial concentration and antigen expression level in bacterial broth of different fermentation culture processes

[0099]

[0100] Note: [1] Yang Yong, Wu Yongchao, Zhang Feiwei, et al. Effects of culture conditions on the expression of pertussis toxin and filamentous hemagglutinin in Bordetella pertussis fermentation[J]. Chinese Journal of Biologicals, 2021, 34(7): 816-823.

[0101] From the results in Table 3, we can see that using mPP1SM medium, the fermentation strain can be obtained in 5-6 days. Combining fermentation culture processes 4 and 6, the bacterial growth rate is faster, the maximum bacterial concentration is higher, and the OD 550 Reaching 11-14, the expression levels of antigens PT and FHA were greatly improved, PT reached 22-25ug / ml fermentation liquid, and FHA reached 50v80ug / ml fermentation liquid.

[0102] In summary, the present invention, on the basis of Stainer-Scholte liquid medium (SS medium), adds specific animal-free peptone, and correspondingly adjusts the dosage ratio of other components, so that the growth rate and the highest bacterial concentration of Bordetella pertussis in the culture process are higher, and the antigen expression amount is also high. The supernatant obtained by fermentation is used as the raw material for vaccine preparation, because it does not contain animal-derived components, it has high safety, and at the same time, the high antigen expression amount lays a foundation for the purification process of Bordetella pertussis.

Claims

1. A Bordetella pertussis culture medium free of animal origin, characterized in that: It is mainly composed of component A and component B; The component A is composed of the following raw materials in parts by weight: Component A: 10.0-20.0 parts of sodium glutamate, 0.1-0.6 parts of proline, 2-7 parts of NaCl, 0.4-1.2 parts of KH2PO4, 0.1-0.5 parts of KCl, 0.05-0.3 parts of MgCl2·6H2O, 6-10 parts of Tris, 1.0-2.0 parts of 2,6-di-O-methyl-β-cyclodextrin, and 0-7.0 parts of yeast peptone; The component B is composed of the following raw materials in parts by weight: Cysteine ​​hydrochloride 0.01-0.05 parts, reduced glutathione 0.05-0.15 parts, FeSO4 . 7H2O 0.005-0.025 parts, ascorbic acid 0.01-0.05 parts, niacin 0.002-0.006 parts; The mass ratio of component A to component B is 19.65-48.6:0.077-0.

281.

2. The animal-derived-free culture medium according to claim 1, characterized in that: The component A is composed of the following raw materials in parts by weight: 12.0 parts of sodium glutamate, 0.3 parts of proline, 2.5 parts of NaCl, 0.6 parts of KH2PO4, 0.2 g of KCl, 0.25 parts of MgCl2·6H2O, 6.1 parts of Tris, 1.0 parts of 2,6-di-O-methyl-β-cyclodextrin, and 5.0 parts of yeast peptone; The component B is composed of the following raw materials in parts by weight: 0.04 parts of cysteine ​​hydrochloride, 0.1 parts of reduced glutathione, FeSO4 . 7H2O 0.015 parts, ascorbic acid 0.02 parts, niacin 0.004 parts; The mass ratio of component A to component B is 27.95:0.

179.

3. The animal-derived-free culture medium according to claim 1 or 2, characterized in that: It also includes component C; the component C is 10.0 to 20.0 parts of agar powder, preferably 15.0 parts of agar powder; The mass ratio of component C to component A and component B is 10.0-20.0:19.65-48.6:0.077-0.281, preferably 15.0:27.95:0.

179.

4. The animal-derived-free culture medium according to claim 1 or 2, characterized in that: The proline is L-proline; the cysteine ​​hydrochloride is L-cysteine ​​hydrochloride; and the ascorbic acid is L-ascorbic acid.

5. Use of the animal-derived-free culture medium according to any one of claims 1 to 4 in fermentation culture of Bordetella pertussis.

6. A fermentation culture method for Bordetella pertussis, characterized in that: It includes the following steps: 1) Take the Bordetella pertussis strain and inoculate it on the solid culture medium for 48-72 hours, wash off the bacterial lawn with water, and inoculate it into the liquid culture medium. The initial OD 550 Controlled at 0.1-0.2, cultured until OD 550 When the OD reaches 4-6, take the bacterial solution and inoculate it into liquid culture medium. 550 Controlled at 0.1-0.2, cultured with aeration and stirring until OD 550 When the value reaches 4-6, the bacteria for fermentation are obtained; 2) Take the fermentation strain obtained in step 1) and inoculate it into a fermentation tank containing liquid culture medium. The initial OD 550 Control the pH value at 0.1-0.2, ventilate and stir the liquid surface, control the DO value at 30%-50%, and the pH value at 7.2-7.6, until the bacteria stop growing; The solid culture medium is prepared by dissolving the culture medium according to claim 3 in water; The liquid culture medium is prepared by dissolving the culture medium according to claim 1 or 2 in water.

7. The fermentation culture method according to claim 6, characterized in that: The preparation method of the solid culture medium is: Take component A and component C, mix them, add 38-40℃ water for injection to dissolve, adjust the pH to 7.1-7.3, sterilize by high pressure, and cool to 40-50℃ to obtain liquid A; take component B, add 38-40℃ water for injection to dissolve, filter to obtain liquid B; mix liquid A and liquid B, and solidify to obtain; The preparation method of the liquid culture medium is: Mix component A and component B, dissolve in 38-40°C water for injection, adjust the pH to 7.1-7.3, and filter to obtain the product.

8. The fermentation culture method according to claim 6, characterized in that: The culture temperature in step 1) is 35-37°C.

9. The fermentation culture method according to claim 6, characterized in that: Step 2) The pH value is adjusted with acid.

10. The fermentation culture method according to claim 8, characterized in that: The acid is hydrochloric acid solution or lactic acid solution.